K133372 is an FDA 510(k) clearance for the CROSSTREES PVA POD. Classified as Cement, Bone, Vertebroplasty (product code NDN), Class II - Special Controls.
Submitted by Crosstrees Medical, Inc. (Philadelphia, US). The FDA issued a Cleared decision on December 6, 2013 after a review of 35 days - a notably fast clearance cycle.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3027 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.
NCT00933036
Completed
Interventional
Industry-sponsored
Clinical Evaluation of the Crosstrees Pod™ in the Treatment of Pathologic Fracture of the Vertebral Body (Levels T4 - L5) in Adult Patients
Clinical Evaluation of the Crosstrees® System for PVA in Symptomatic Adult Patients With Acute Vertebral Body Compression Fractures at T4-L5
| Condition studied |
Pathologic Fracture of the Vertebra Due to Osteoporosis |
| Study design |
Single group |
| Eligibility |
All sexes
· 50 Years+
|
| Principal investigator |
Frank M Phillips, MD |
| Sponsor |
Crosstrees Medical Inc.
(industry)
|
Started 2009-06-01
→
Primary completion 2013-06-01
Primary outcome
Clinically significant improvement in pain as measured using a 10 mm Visual Analog Scale (VAS). In this scale 0 means "no pain" and 10 is "Severe pain". A difference of at least 2 points compared to baseline is regarded as clinically relevant.
Secondary outcome
Ambulatory Status/Physical Function
Study completed - no results published.
This trial concluded in 2013 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
View full study on ClinicalTrials.gov